Malignant struma ovarii - A case report and review of the literature

Gynecologic and Obstetric Investigation

Volumn 65, Issue 2, 2008, Pages 104-107

  Hatami, Mehrangiz ^a,b,c   Breining, Dwayne ^a   Owers, Ricky L ^a   Del Priore, Giuseppe ^a   Goldberg, Gary L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Division of Gynecologic Oncology   (United States)

Author keywords

Germ cell tumor; Malignant struma ovarii; Ovarian teratoma; Papillary carcinoma of thyroid

Indexed keywords

IODINE 131;

ADULT; APPENDECTOMY; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALIGNANT TERATOMA; OVARY TERATOMA; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, PAPILLARY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; STRUMA OVARII; THYROID NEOPLASMS;

EID: 40349089059     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108654     Document Type: Article

References (23)

1. Kabukcuoglu F, Baksu A, Yilmaz B, Aktumen A, Evren I: Malignant struma ovarii. Pathol Oncol Res 2002;8:145-147.
2. Kostoglou-Athanassiou I, Lekka-Katsouli I, Gogou L, Papagrigoriou L, Chatonides I, Kaldrymides P: Malignant struma ovarii: report of a case and review of the literature. Horm Res 2002;58:34-38.
3. Devaney K, Snyder R, Norris HJ, Tavassoli FA: Related articles, proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993;2:333-343.
4. Matsuda K, Maehama T, Kanazawa K: Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001;82:575-577.
5. Doldi N, Taccagni GL, Basin M, Frigerio L, Mangili G, Jansen AM, Ferrari A: Hashimoto's disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecol Endocrinol 1998;12:41-42.
6. Kano H, Inoue M, Nishino T, Yoshimoto Y, Arima R: Malignant struma ovarii with Graves' disease. Gynecol Oncol 2000;79:508-510.
7. Ciccarelli A, Valdes-Socin H, Parma J, Khoo SK, Schoumans J, Colao A, Hamoir E, Beckers A: Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies. Eur J Endocrinol 2004;150:431-437.
8. Ayhan A, Yanik F, Tuncer ZS, Ruacan S: Struma ovarii. Int J Gynaecol Obstet 1993;42:143-146.
9. Piraneo S, Vago L, Gobbi G, Vitri P, Casati M, Bastagli A: Ovarian and cervical thyroid struma: a case report. Ital J Surg Sci 1989;19:273-276.
10. Rotman-Pikielny P, Reynolds JC, Barker WC, Yen PM, Skarulis MC, Sarlis NJ: Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. J Clin Endocrinol Metab 2000;85:237-244.
11. Makani S, Kim W, Gaba AR: Struma ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 2004;94:835-839.
12. Altaras M, Goldberg GL, Levin W, et al: CA125 - A new tumor marker for germ cell tumors of the ovary. Br Med J 1985;290:1112.
13. Altaras M, Goldberg GL, Levin W, et al: The value of CA125 as a tumor marker in malignant germ cell tumors of the ovary. Gynecol Oncol 1986;25:150-159.
14. Rose PG, Arafah B, Abdul-Karim FW: Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 1998;70:425-427.
15. Bethune M, Quinn M, Rome R: Struma ovarii presenting as acute pseudo-Meigs syndrome with an elevated CA 125 level. Aust NZ J Obstet Gynaecol 1996;36:372-373.
16. Zannoni GF, Gallotta V, Legge F, Tarquini E, Scambia G, Ferrandina G: Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report. Gynecol Oncol 2004;94:226-228.
17. Huh JJ, Montz FJ, Bristow RE: Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125. Gynecol Oncol 2002;86:231-234.
18. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, De Groot LJ: Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994;79:98-105.
19. Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, Wahl R, Tufano RP: The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 2005;115:237-243.
20. Volpi E, Ferrero A, Nasi PG, Sismondi P: Malignant struma ovarii: a case report of laparoscopic management. Gynecol Oncol 2003;90:191-194.
21. Brenner W, Bohuslavizki KH, Wolf H, Sippel C, Clausen M, Henze E: Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med 1996;23:91-94.
22. Willemse PH, et al: Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131-I administration. Cancer 1987;60:178-182.
23. DeSimone CP, Lele SM, Modesitt SC: Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol 2003;89:543-548.